Literature DB >> 27169613

Long-term survival of donor bone marrow multipotent mesenchymal stromal cells implanted into the periosteum of patients with allogeneic graft failure.

L A Kuzmina1, N A Petinati1, N V Sats1, N J Drize2,3, N V Risinskaya1, A B Sudarikov1, V A Vasilieva1, M Y Drokov1, E D Michalzova1, E N Parovichnikova1, V G Savchenko1.   

Abstract

The present study involved three patients with graft failure following allogeneic hematopoietic stem cell transplantation (allo-HSCT). We obtained multipotent mesenchymal stromal cells (MSCs) from the original hematopoietic cell donors and implanted these cells in the periosteum to treat long-term bone marrow aplasia. The results showed that in all patients endogenous blood formation was recovered 2 weeks after MSC administration. Donor MSCs were found in recipient bone marrow three and 5 months following MSC implantation. Thus, our findings indicate that functional donor MSCs can persist in patient bone marrow.

Entities:  

Keywords:  Allogeneic hematopoietic stem cell transplantation (allo-HSCT); Graft failure; Multipotent mesenchymal stromal cells (MSCs); Periosteal implantation

Mesh:

Year:  2016        PMID: 27169613     DOI: 10.1007/s12185-016-2014-2

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  17 in total

1.  [The basic properties of mesenchymal stromal cells from the donor bone marrow: superficial markers].

Authors:  D A Svinareva; I N Shipunova; Iu V Ol'shanskaia; K S Momotiuk; N I Drize; V G Savchenko
Journal:  Ter Arkh       Date:  2010       Impact factor: 0.467

2.  Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement.

Authors:  M Dominici; K Le Blanc; I Mueller; I Slaper-Cortenbach; Fc Marini; Ds Krause; Rj Deans; A Keating; Dj Prockop; Em Horwitz
Journal:  Cytotherapy       Date:  2006       Impact factor: 5.414

Review 3.  Chimerism of bone marrow mesenchymal stem/stromal cells in allogeneic hematopoietic cell transplantation: is it clinically relevant?

Authors:  Yasuo Miura; Satoshi Yoshioka; Hisayuki Yao; Akifumi Takaori-Kondo; Taira Maekawa; Tatsuo Ichinohe
Journal:  Chimerism       Date:  2013-07-11

4.  Analysis of multipotent mesenchymal stromal cells used for acute graft-versus-host disease prophylaxis.

Authors:  Larisa A Kuzmina; Nataliya A Petinati; Irina N Shipounova; Natalia V Sats; Alexey E Bigildeev; Ekaterina A Zezina; Maria D Popova; Nina J Drize; Elena N Parovichnikova; Valery G Savchenko
Journal:  Eur J Haematol       Date:  2015-07-20       Impact factor: 2.997

Review 5.  Mesenchymal cell contributions to the stem cell niche.

Authors:  Youmna Kfoury; David T Scadden
Journal:  Cell Stem Cell       Date:  2015-03-05       Impact factor: 24.633

6.  [Characteristics of stromal cell precursors in patients after allogeneic bone marrow transplantation].

Authors:  N A Petinati; I N Shipunova; A E Bigil'deev; L A Kuz'mina; R A Saribekian; I V Gal'tseva; A V Misiurin; E N Parovichnikova; V G Savchenko; N I Drize
Journal:  Ter Arkh       Date:  2013       Impact factor: 0.467

Review 7.  Human bone marrow mesenchymal stromal/stem cells: current clinical applications and potential for hematology.

Authors:  Yasuo Miura
Journal:  Int J Hematol       Date:  2015-12-21       Impact factor: 2.490

Review 8.  Immunological aspects of allogeneic mesenchymal stem cell therapies.

Authors:  Matthew D Griffin; Thomas Ritter; Bernard P Mahon
Journal:  Hum Gene Ther       Date:  2010-12       Impact factor: 5.695

9.  CXCR4 receptor overexpression in mesenchymal stem cells facilitates treatment of acute lung injury in rats.

Authors:  Jing-Xian Yang; Nan Zhang; Han-Wei Wang; Peng Gao; Qing-Ping Yang; Qing-Ping Wen
Journal:  J Biol Chem       Date:  2014-12-09       Impact factor: 5.157

Review 10.  Homing and engraftment of progenitor cells: a prerequisite for cell therapy.

Authors:  Emmanouil Chavakis; Carmen Urbich; Stefanie Dimmeler
Journal:  J Mol Cell Cardiol       Date:  2008-01-18       Impact factor: 5.000

View more
  2 in total

1.  Nestin-GFP transgene labels immunoprivileged bone marrow mesenchymal stem cells in the model of ectopic foci formation.

Authors:  Dmitriy Karpenko; Nikolay Kapranov; Aleksei Bigildeev
Journal:  Front Cell Dev Biol       Date:  2022-09-05

2.  Recovery of Donor Hematopoiesis after Graft Failure and Second Hematopoietic Stem Cell Transplantation with Intraosseous Administration of Mesenchymal Stromal Cells.

Authors:  Nataliya Petinati; Nina Drize; Natalia Sats; Natalya Risinskaya; Andrey Sudarikov; Michail Drokov; Daria Dubniak; Alina Kraizman; Maria Nareyko; Natalia Popova; Maya Firsova; Larisa Kuzmina; Elena Parovichnikova; Valeriy Savchenko
Journal:  Stem Cells Int       Date:  2018-04-10       Impact factor: 5.443

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.